Related Experiment Video
Updated: Sep 20, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
Published on: December 19, 2014
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy
Jane V Trinh1, William J Steinbach, Wiley A Schell
1Department of Pediatrics, Duke University, Durham, North Carolina 27710, USA.
Abstract:
Cerebral phaeohyphomycosis is a rare fungal infection with a poor prognosis when using conventional antifungal therapy in the absence of neurosurgical intervention. We present a case of a pediatric patient with inoperable Cladophialophora bantiana cerebral abscesses. To our knowledge, this child's case is the first reported to be treated with the combination of the newer triazole voriconazole and the new echinocandin caspofungin. Although our patient subsequently died, the natural rapid progression of the disease seemed to be altered by the antifungal combination alone, in the absence of surgery. Despite the fatal outcome for our patient, we encourage other clinicians to try unique medical approaches for this historically life-threatening infection when adjunctive surgery is impossible.
Insights
Cerebral phaeohyphomycosis, a rare fungal infection, has a poor prognosis. A pediatric case showed voriconazole and caspofungin combination therapy may alter disease progression, even without surgery.
Area of Science:
- Mycology
- Infectious Diseases
- Pediatric Neurology
Background:
- Cerebral phaeohyphomycosis is a rare, life-threatening fungal infection of the brain.
- Conventional antifungal therapy often has a poor prognosis, especially without neurosurgical intervention.
- Cladophialophora bantiana is a causative agent of cerebral phaeohyphomycosis.
Observation:
- A pediatric patient presented with inoperable Cladophialophora bantiana cerebral abscesses.
- The patient received a combination of voriconazole and caspofungin.
- The patient's outcome was fatal, but disease progression appeared altered by the antifungal treatment.
Findings:
- This is the first reported case of cerebral phaeohyphomycosis treated with voriconazole and caspofungin combination therapy.
- The combination therapy, in the absence of surgery, appeared to modify the rapid progression of the fungal infection.
- Despite the fatal outcome, the antifungal combination demonstrated a potential effect on disease course.
Implications:
- Novel antifungal combinations may offer therapeutic options for inoperable cerebral phaeohyphomycosis.
- Further investigation into medical management of this rare infection is warranted.
- Clinicians should consider exploring unique medical approaches for life-threatening fungal brain infections when surgery is not feasible.
Related Concept Videos
Cryptococcal Meningitis
Fungal Phylum Microsporidia
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Antifungal Agents
Candidiasis
Rocky Mountain Spotted Fever